Homocysteine and nitric oxide are related to blood pressure and vascular function in small-for-gestational-age children

Hypertension

Volumn 50, Issue 2, 2007, Pages 396-402

  Franco, Maria C P ^a   Higa, Elisa M S ^a   D'Almeida, Vânia ^a   De Sousa, Fernanda G ^a   Sawaya, Ana L ^a   Fortes, Zuleica B ^b   Sesso, Ricardo ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Blood pressure; Children; Endothelium function; Homocysteine; NO

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; HOMOCYSTEINE; LEPTIN; NITRIC OXIDE;

ADOLESCENT; ARTICLE; BIRTH WEIGHT; BLOOD PRESSURE REGULATION; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD; SMALL FOR DATE INFANT;

ADOLESCENT; AGE DISTRIBUTION; BIOLOGICAL MARKERS; BLOOD PRESSURE; C-REACTIVE PROTEIN; CARDIOVASCULAR PHYSIOLOGY; CHILD; COHORT STUDIES; CONFIDENCE INTERVALS; FEMALE; FOLLOW-UP STUDIES; HOMOCYSTEINE; HUMANS; HYPERTENSION; INCIDENCE; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; LEPTIN; MALE; NITRIC OXIDE; PROBABILITY; REFERENCE VALUES; RISK ASSESSMENT; SEX DISTRIBUTION; TERM BIRTH;

EID: 34547643346     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.107.091223     Document Type: Article

References (33)

1. Barker DJ. Fetal origins of cardiovascular disease. Ann Intern Med. 1999;31:3-6.
2. Barker DJ. The fetal origins of type 2 diabetes mellitus. Ann Intern Med. 1999;130:322-324.
3. Barker DJ, Gluckman PD, Godfrey KM, Harding JE, Owens JA, Robinson JS. Fetal nutrition and cardiovascular disease in adult life. Lancet. 1993;341:938-941.
4. Mori A, Uchida N, Inomo A, Izumi S. Stiffness of systemic arteries in appropriate- and small-for-gestational-age newborn infants. Pediatrics. 2006;118:1035-1041.
5. Franco MC, Christofalo DM, Sawaya AL, Ajzen SA, Sesso R. Effects of low birth weight in 8- to 13-year-old children: implications in endothelial function and uric acid levels. Hypertension. 2006;48:45-50.
6. Martin H, Hu J, Gennser G, Norman M. Impaired endothelial function and increased carotid stiffness in 9-year-old children with low birth-weight. Circulation. 2000;102:2739-2744.
7. Rifai N, Ridker PM. High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Clin Chem. 2001;47:403-411.
8. Tayama J, Munakata M, Yoshinaga K, Toyota T. Higher plasma homocysteine concentration is associated with more advanced systemic arterial stiffness and greater blood pressure response to stress in hypertensive patients. Hypertens Res. 2006;29:403-409.
9. Tsuda K, Nishio I. Leptin and nitric oxide production in normotensive and hypertensive men. Obes Res. 2004;12:1223-1237.
10. Panza JA, Garcia CE, Kilcoyne CM, Quyyumi AA, Cannon RO. Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway. Circulation. 1995;91:1732-1738.
11. Chan NN, Vallance P, Colhoun HM. Nitric oxide and vascular responses in type I diabetes. Diabetologia. 2000;43:137-147.
12. Becker JS, Adler A, Schneeberger A, Huang H, Wang Z, Walsh E, Koller A, Hintze TH. Hyperhomocysteinemia, a cardiac metabolic disease: role of nitric oxide and the p22phox subunit of NADPH oxidase. Circulation. 2005;111:2112-2118.
13. Clapp BR, Hirschfield GM, Storry C, Gallimore JR, Stidwill RP, Singer M, Deanfield JE, Vallance P, Hingorani AD. Inflammation and endothelial function: direct vascular effects of human C-reactive protein on nitric oxide bioavailability. Circulation. 2005;111:1530-1536.
14. National Center for Health Statistics (NCHS). Growth Curves for Children, Birth-18 Years. Hyattsville; DHEW Publishers; 2000: PHS578-1650(Ser 11, No. 165).
15. Pfweiffer CM, Huff DL, Gunter EW. Rapid and accurate HPLC assay for plasma to homocysteine and cysteine in a clinical laboratory setting. Clin Chem. 1999;45:290-292.
16. Gillum RF. Association of serum C-reactive protein and indices of body fat distribution and overweight in Mexican American children. J Natl Med Assoc. 2003;95:545-552.
17. Cook DG, Mendall MA, Whincup PH, Carey IM, Ballam L, Morris JE, Miller GJ, Strachan DP. C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors. Atherosclerosis. 2000;149:139-150.
18. Sattar N, McConnachie A, O'Reilly D, Upton MN, Greer IA, Davey Smith G, Watt G. Inverse association between birth weight and C-reactive protein concentrations in the MIDSPAN Family Study. Arterioscler Thromb Vasc Biol. 2004;24:583-587.
19. Pulzer F, Haase U, Knupfer M, Kratzsch J, Richter V, Rassoul F, Kiess W, Keller E. Serum leptin in formerly small-for-gestational-age children during adolescence: relationship to gender, puberty, body composition, insulin sensitivity, creatinine, and serum uric acid. Metabolism. 2001;50:1141-1146.
20. Jaquet D, Leger J, Tabone MD, Czernichow P, Levy-Marchal C. High serum leptin concentrations during catch-up growth of children born with intrauterine growth retardation. J Clin Endocrinol Metab. 1999;84:1949-1953.
21. Holness MJ, Sugden MC. Epigenetic regulation of metabolism in children born small for gestational age. Curr Opin Clin Nutr Metab Care. 2006;9:482-488.
22. Tenhola S, Halonen P, Jaaskelainen J, Voutilainen R. Serum markers of GH and insulin action in 12-year-old children born small for gestational age. Eur J Endocrinol. 2005;152:335-340.
23. Albertsson-Wikland K, Boguszewski M, Karlberg J. Children born smallfor-gestational age: postnatal growth and hormonal status. Horm Res. 1998;49(suppl 2):7-13.
24. Grandone E, Colaizzo D, Vecchione G, Scianname N, Notarangelo A, Croce AI, Margaglione M. Homocysteine levels in amniotic fluid. Relationship with birth-weight. Thromb Haemost. 2006;95:625-628.
25. Yajnik CS, Deshpande SS, Panchanadikar AV, Naik SS, Deshpande JA, Coyaji KJ, Fall C, Refsum H. Maternal total homocysteine concentration and neonatal size in India. Asia Pac J Clin Nutr. 2005;14:179-181.
26. Engel SM, Olshan AF, Siega-Riz AM, Savitz DA, Chanock SJ. Polymorphisms in folate metabolizing genes and risk for spontaneous preterm and small-for-gestational age birth. Am J Obstet Gynecol. 2006;195:1-11.
27. Rutherford RA, McCarthy A, Sullivan MH, Elder MG, Polak JM, Wharton J. Nitric oxide synthase in human placenta and umbilical cord from normal, intrauterine growth-retarded and pre-eclamptic pregnancies. Br J Pharmacol. 1995;116:3099-3109.
28. Hata T, Hashimoto M, Manabe A, Aoki S, Iida K, Masumura S, Miyazaki K. Maternal and fetal nitric oxide synthesis is decreased in pregnancies with small for gestational age infants. Hum Reprod. 1998;13:1070-1073.
29. Schiessl B, Strasburger C, Bidlingmaier M, Mylonas I, Jeschke U, Kainer F, Friese K. Plasma- and urine concentrations of nitrite/nitrate and cyclic Guanosinemonophosphate in intrauterine growth restricted and preeclamptic pregnancies. Arch Gynecol Obstet. 2006;274:150-154.
30. Lyall F, Greer IA, Young A, Myatt L. Nitric oxide concentrations are increased in the feto-placental circulation in intrauterine growth restriction. Placenta. 1996;17:165-168.
31. Wijnberger LD, Krediet TG, Egberts J, van Bel F. Nitric oxide production during the early neonatal period in small-for-gestational-age infants. Acta Paediatr. 2001;90:569-572.
32. Kang DH, Park SK, Lee IK, Johnson RJ. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol. 2005;16:3553-3562.
33. Hattersley AT, Tooke J. The fetal insulin hypothesis: an alternative explanation of the association of low birth weight with diabetes and vascular disease. Lancet. 1999;353:1789-1792.